Movement of tuberculosis patients and the failure to complete antituberculosis treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 PART I, 1998, Pages 1249-1252

  Cummings, Kate C ^a   Mohle Boetani, Janet ^a   Royce, Sarah E ^a   Chin, Daniel P ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG DEPENDENCE; FEMALE; HOMELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRATION; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRISON; RISK FACTOR; TREATMENT FAILURE; TUBERCULOSIS; UNITED STATES;

EID: 0031979298     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.9708058     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. 1995. Essential components of a tuberculosis prevention and control program. Morbid. Mortal. Weekly Rep. 44(RR-11):1-34.
2. Hong Kong Chest Service/British Medical Research Council. 1991. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month three times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide: results at 30 months. Am. Rev. Respir. Dis. 143:700-706.
3. Singapore Tuberculosis Service/British Medical Research Council. 1979. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 119:579-585.
4. Hong Kong Chest Service/British Medical Research Council. 1981. A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the resuits at 30 months. Am. Rev. Respir. Dis. 124:138-142.
5. Mahmoudi, A., and M. D. Iseman. 1993. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. J.A.M.A. 270:65-68.
6. Centers for Disease Control and Prevention. 1991. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility-Michigan. Morbid. Mortal. Weekly Rep. 40:129-131.
7. Centers for Disease Control and Prevention. 1990. Outbreak of multidrug-resistant tuberculosis - Texas, California, and Pennsylvania. Morbid. Mortal. Weekly Rep. 39:369-372.
8. Centers for Disease Control and Prevention. 1983. Interstate outbreak of drug resistant tuberculosis involving children - California, Montana, Nevada, Utah. Morbid. Mortal. Weekly Rep.32:516-518.
9. Bifani, P. J., B. B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M. L. Lutfey, S. L. Moghazeh, W. Eisner, T. M. Daniel, M. H. Kaplan, J. T. Crawford, J. M. Musser, and B. N. Kreiswirth. 1996. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. J.A.M.A. 275:452-457.
10. Bloch, A. B., P. M. Simone, E. McCray, and K. G. Castro. 1996. Preventing multidrug-resistant tuberculosis. J.A.M.A. 275:487-489.
11. Centers for Disease Control and Prevention. 1990. Case definitions for public health surveillance. Morbid. Mortal. Weekly Rep. 39(RR-13):39-40.
12. McCombs, S. B., I. M. Onorato, E. McCray, and K. G. Castro. 1996. Tuberculosis surveillance in the United States: case definitions used by state health departments. Am. J. Public Health 86:728-731.
13. Bloch, A. B., I. M. Onorato, W. Ihle, C. Hayden, and D. Snider. 1996. Expanded tuberculosis surveillance in the United States: the need for epidemic intelligence. Public Health Rep. 111:26-31. (Erratum: 1996. Public Health Rep. 111:98.)
14. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41(RR-17):1-19.
15. Daley, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length-polymorphisms. N. Engl. J. Med. 326:231-235.
16. Barnes, P. F., H. El-Hajj, S. Preston-Martin, D. Cave, B. E. Jones, M. Otaya, J. Pogoda, and K. D. Eisenach. 1996. Transmission of tuberculosis among the urban homeless. J.A.M.A. 275:305-307.
17. Layton, M. C., M. F. Cantwell, G. J. Dorsinville, S. E. Valway, I. M. Onorato, and T. R. Frieden. 1995. Tuberculosis screening among homeless persons with AIDS living in single-room occupancy hotels. Am. J. Public Health 85:1556-1559.
18. Zolopa, A. R., J. A. Hahn, R. Gorter, J. Miranda, D. Wlodarczyk, J. Peterson, L. Pilote, and A. Moss. 1994. HIV and tuberculosis infection in San Francisco's homeless adults. J.A.M.A. 272:455-461.
19. Valway, S. E., R. B. Greifinger, M. Papania, J. O. Kilburn, C. Woodley, G. T. DiFerdinando, and S. Dooley. 1994. Multidrug-resistant tuberculosis in the New York state prison system, 1990-1991. J. Infect. Dis. 170:151-156.
20. Bloch, A. B., P. M. Simone, G. D. Kelly, K. G. Dansury, E. McCray, and K. G. Castro. 1997. Comparison of two methods for calculating completion of tuberculosis therapy in the U.S., 1993 (abstract). Am. J. Respir. Crit. Care Med. 155:A256.
21. Cummings, K., J. Mohle-Boetani, and S. Royce. 1996. Completion of therapy among California tuberculosis patients 1993-1994 (abstract). Am. J. Respir. Crit. Care Med. 153:A333.